Overall CNTX gets a fundamental rating of 3 out of 10. We evaluated CNTX against 191 industry peers in the Pharmaceuticals industry. CNTX has a great financial health rating, but its profitability evaluates not so good. CNTX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CNTX has reported negative net income.
In the past year CNTX has reported a negative cash flow from operations.
In the past 5 years CNTX reported 4 times negative net income.
CNTX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

CNTX has a Return On Assets (-33.47%) which is comparable to the rest of the industry.
With a Return On Equity value of -36.22%, CNTX perfoms like the industry average, outperforming 58.64% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-33.47%
ROE	-36.22%
ROIC	N/A

ROA(3y)-72.21%

ROA(5y)235.15%

ROE(3y)-90.37%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CNTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for CNTX has been increased compared to 1 year ago.
The number of shares outstanding for CNTX has been increased compared to 5 years ago.
CNTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 14.02 indicates that CNTX is not in any danger for bankruptcy at the moment.
CNTX has a Altman-Z score of 14.02. This is amongst the best in the industry. CNTX outperforms 83.25% of its industry peers.
CNTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	14.02

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 13.08 indicates that CNTX has no problem at all paying its short term obligations.
The Current ratio of CNTX (13.08) is better than 81.68% of its industry peers.
A Quick Ratio of 13.08 indicates that CNTX has no problem at all paying its short term obligations.
CNTX has a Quick ratio of 13.08. This is amongst the best in the industry. CNTX outperforms 81.68% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	13.08
Quick Ratio	13.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CNTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.23%, which is quite impressive.

EPS 1Y (TTM)69.23%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%54.55%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CNTX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.39% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y32.81%

EPS Next 2Y9.99%

EPS Next 3Y7.15%

EPS Next 5Y11.39%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CNTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNTX. No positive earnings are expected for the next year.